Last reviewed · How we verify
NCT05766553: VIREAMIND
Effects of Mindfulness Meditation in Virtual Reality on Craving and Smoking Cessation
NA trial testing Virtual reality pod in Tobacco Use Disorder in 200 participants. Currently enrolling.
15 October 2026
Quick facts
| Lead sponsor | Centre Hospitalier Henri Laborit |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 15 June 2023 |
| Primary completion | 15 October 2026 |
| Estimated completion | 15 December 2026 |
| Sites | 3 locations across France |
Drugs / interventions tested
- Virtual reality pod
- nicotine patches and chewing gum
Conditions studied
- Tobacco Use Disorder — all drugs for Tobacco Use Disorder →
Sponsor
Centre Hospitalier Henri Laborit
Who can join
Adults 18 to 75, any sex, with Tobacco Use Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Investigators seek to propose a non-drug therapeutic alternative, namely a mindfulness meditation protocol based on virtual reality training in order to induce progressive modifications of various indicators of craving. The study hypothesis is that the practice of mindfulness meditation in a virtual reality environment reduces the craving induced by cues and stress and therefore ultimately smoking relapse. The main objective of the protocol will be to demonstrate that mindfulness meditation can reduce long-term relapse (continuous cessation (\> 30 days) of smoking cessation). The participants will be randomized into two groups: the experimental group will perform six virtual reality sessions in a multisensory cabin at the rate of one session per week; the control group will be prescribed the gold standard treatment (nicotine patches and chewing gum). Participants will be seen again at three and six months to assess whether or not there has been a smoking relapse.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05766553
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Tobacco Use Disorder
Currently open trials in the same condition.
- NCT07466875 — Auricular Stimulation for Nicotine Withdrawal in Psychiatric Inpatients · NA · recruiting
- NCT06678672 — Contingency Management for Veteran Smokers Undergoing Major Elective Surgery · NA · recruiting
- NCT06006143 — Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2 · Phase 2 · active not recruiting
- NCT06883162 — Cannabis-Tobacco Co-Use Treatment Study · Phase 3 · recruiting
- NCT06798324 — tDCS Plus Varenicline for Smoking Cessation · Phase 4 · recruiting
Other Centre Hospitalier Henri Laborit trials
Trials by the same sponsor.
- NCT07429500 — tDCS and Symptom Provocation in Treatment-Resistant OCD · NA · not yet recruiting
- NCT07015502 — Self-Dehumanization and Hesitation to Report Domestic Violence · recruiting
- NCT07274722 — Influence of Control Deprivation on the Use of the Analytical Cognitive Style in Anorexic Subjects · NA · recruiting
- NCT06093919 — Study of Prevalence of Eating Disorder in Liver Transplant Patients · completed
- NCT06009523 — Effects of Transcranial Direct Current Stimulation (tDCS) in the Management of Suicidal Ideation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05766553 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre Hospitalier Henri Laborit
- Last refreshed: 13 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05766553.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing